These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Clinical biochemical justification for the use of fibrinolysis inhibitors in the therapy of hemorrhages in ENT diseases]. Veremeenko KN; Gerasimenko NG; Pogorelova LM Zh Ushn Nos Gorl Bolezn; 1972; (3):56-61. PubMed ID: 4680879 [No Abstract] [Full Text] [Related]
26. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)]. Markwardt F; Neuland P; Klöcking HP Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982 [No Abstract] [Full Text] [Related]
27. [Influencing of hematuria, following prostatectomy, by p-aminomethylbenzoic acid (PAMBA)]. Preusser KP; Neef H; Anger G Langenbecks Arch Chir; 1967; 317(2):117-23. PubMed ID: 6082920 [No Abstract] [Full Text] [Related]
28. Fibrinolysis in surgery : personal experience with chest operations. Aguilar HD Indian J Chest Dis; 1974 Sep; 16 Suppl():310-21. PubMed ID: 4442936 [No Abstract] [Full Text] [Related]
29. [Fibrinolytic hemorrhage and antifibrinolytic preparations]. Panchenko M Klin Med (Mosk); 1969 Mar; 47(3):11-7. PubMed ID: 5406805 [No Abstract] [Full Text] [Related]
30. Use of tranexamic acid, AMCA for the improvement of hemorrhagic manifestations in hemophilia. Donner L; Klener P Vnitr Lek; 1971 Sep; 17(9):846-50. PubMed ID: 5129130 [No Abstract] [Full Text] [Related]
31. [PAMBA prophylaxis in prostatectomies]. Neef H; Preusser KP; Anger G Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):197-202. PubMed ID: 4174659 [No Abstract] [Full Text] [Related]
32. Comparative studies of the effect of fibrinolytic inhibitors (synthetic and naturally occurring substances) on coagulation and fibrinolytic systems in vitro and in vivo, and their clinical applications. Matsuoka M; Sakuragawa N; Yoneyama Y Acta Med Biol (Niigata); 1969 Mar; 16(3):105-20. PubMed ID: 4239124 [No Abstract] [Full Text] [Related]
33. [On the combined effect of PAMBA and contrykal]. Richter M; Markwardt F Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):90-2. PubMed ID: 4189379 [No Abstract] [Full Text] [Related]
34. [Behavior of plasmatic fibrinolytic activity after adeno-tonsillectomy]. Conticello S; Lombardo C; Terranova R Ann Laringol Otol Rinol Faringol; 1967; 66(3):373-9. PubMed ID: 5632639 [No Abstract] [Full Text] [Related]
35. [Hyperfibrinolysis as the cause of so-called "spontaneous hemorrhages"]. Perlick E Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):57-63. PubMed ID: 4189373 [No Abstract] [Full Text] [Related]
36. [Fibrinolytic hemorrhages and their treatment by p-aminomethylbenzoic acid]. Sundermann A Verh Dtsch Ges Inn Med; 1965; 71():749-53. PubMed ID: 5298271 [No Abstract] [Full Text] [Related]
37. Fibrinolysis and its control. Andersson L S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535 [No Abstract] [Full Text] [Related]
38. [On the influencing of tumor metastasis by the antifibrinolytic agent PAMBA]. Wolf M; Rieche K Zentralbl Chir; 1967; 92(26a Pt 2):1742-5. PubMed ID: 5588580 [No Abstract] [Full Text] [Related]
39. [Renal hemorrhage caused by a presumable rise of urokinase activity]. Vogel G; Sundermann A Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 85(1):70-3. PubMed ID: 4165542 [No Abstract] [Full Text] [Related]
40. [Prevention of tissue hemorrhage following conization of the cervix uteri using antifibrinolytics]. Koutský J; Rybák M; Kraus I; Kanka J; Svoboda B Zentralbl Gynakol; 1974 Nov; 96(46):1455-9. PubMed ID: 4454791 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]